Press Release Archive

(BUSINESS WIRE)--Pfizer Inc announced today that Greg Simon has joined the company as Senior Vice President, Worldwide Policy. He comes to Pfizer from the presidency of FasterCures, where he led efforts to reform policies governing biopharmaceutical discovery and development, with the goal of bringing a greater number of lifesaving medicines more quickly to doctors and patients. “Greg and his record of leadership are well-known

(BUSINESS WIRE)--Pfizer Inc announced today that Freda Lewis-Hall, M.D., has been appointed as Chief Medical Officer and Senior Vice President, Pfizer Inc. Dr. Lewis-Hall will be the senior physician in the company, responsible for enterprise-wide medical, patient safety, regulatory affairs and quality assurance as well as outreach to doctors and other medical professionals. She joins Pfizer from Vertex Pharmaceuticals, where she was

(BUSINESS WIRE)--Pfizer Inc invites investors and the general public to view and listen to a webcast of a presentation by Jean-Michel Halfon, President and General Manager, Emerging Markets, at the Bernstein Pharmaceutical Emerging Markets Conference on Wednesday, May 6, 2009 at 8:45 a.m. Eastern Daylight Savings Time. To view and listen to the webcast, visit our web site at www.pfizer.com and click on the “Bernstein

(BUSINESS WIRE)--According to the World Health Organization (WHO) malaria infects approximately 250 million people per year throughout the developing world and results in a grave loss of life of at least 880,000 per year. The region most severely afflicted is Sub-Saharan Africa, but the disease is also present in Asia, Latin America, the Middle East and some parts of Europe. Pfizer recognizes the important role a pharmaceutical

(BUSINESS WIRE)--The board of directors of Pfizer Inc today declared a 16-cent second-quarter 2009 dividend on the company’s common stock, payable June 2, 2009, to shareholders of record at the close of business on May 8, 2009. The second-quarter 2009 cash dividend will be the 282nd consecutive quarterly dividend paid by Pfizer. At the company’s Annual Meeting of Shareholders, Chairman and Chief Executive

(BUSINESS WIRE)--Newly released findings from the BRIDGE survey (Bridging Gaps, Expanding Outreach – Metastatic Breast Cancer Patient Survey) found that most (78 percent) women living with metastatic breast cancer (MBC) have never participated in a clinical trial. Of these women, more than half (56 percent) were never invited to consider a clinical trial and one-third (30 percent) had not been recommended a clinical trial by their

(BUSINESS WIRE)--Pfizer Investments Netherlands B.V., an indirect wholly-owned subsidiary of Pfizer Inc, announced today that it will make a tender offer to acquire a 33.77% stake in Pfizer Limited from public shareholders at a price of Rs. 675.00 per share. Successful completion of this offer, assuming full acceptance, would raise the indirect stake of Pfizer Inc in Pfizer Limited to 75% from the current level of 41.23%. The

(BUSINESS WIRE)--Pfizer (NYSE: PFE) today announced the planned leadership and organizational structure for its research and commercial operations that will become effective when the Wyeth acquisition closes. The company will establish a unique research model designed to advance the strong scientific capabilities of both Pfizer and Wyeth (NYSE: WYE) and to support the new company’s nine diverse health care businesses. At the

(BUSINESS WIRE)--Pfizer Inc announced today that it has become the first pharmaceutical company to be accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) for ensuring the protection of human subjects taking part in early-stage clinical trials. The AAHRPP accreditation was awarded to Pfizer’s clinical research units (CRUs) in New Haven, CT, Brussels, Belgium and Singapore, where the